Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
67
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
26 Mar 2023 10:10
Hong Kong Connect Flows (Mar 24th): Meituan, Tencent, Bilibili
We analyzed the Hong Kong Connect Scheme for last week and highlight flows for Meituan (3690 HK), Tencent (700 HK), and Bilibili (9626 HK).
Ke Yan, CFA, FRM
Follow
321 Views
Share
bullish
•
Quantitative Analysis
•
05 Mar 2023 10:05
Hong Kong Connect Flows (Mar 1st): Tencent, Great Wall Motor, CCB, HKEx
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent, Great Wall Motor, CCB, Hong Kong Exchanges And...
Ke Yan, CFA, FRM
Follow
350 Views
Share
bullish
•
Keymed Biosciences
•
28 Feb 2023 08:55
Keymed Biosciences (2162.HK) - The $1.2B Deal with AstraZeneca for ADC and the Logic Behind
It’s wise decision for Keymed to out-license CMG901 and receive cashflow in advance due to uncertainties.Biotech has to rely on Big Pharma in post...
Xinyao (Criss) Wang
Follow
212 Views
Share
bearish
•
Thematic (Sector/Industry)
•
26 Feb 2023 09:13
China Healthcare Weekly (Feb.24) - No. 1 Central Document, 8th National VBP, TCM Formula Granules
China unveiled "No. 1 central document" to enhance the development of rural medical market. The 8th national VBP is coming. Pfizer is under heavy...
Xinyao (Criss) Wang
Follow
357 Views
Share
bullish
•
Keymed Biosciences
•
21 Feb 2023 08:55
Keymed Biosciences (2162.HK) - We Have High Hopes for Keymed, but Valuation Is Expensive
Keymed is pragmatic in R&D/commercialization, which set it apart from other biotech. We have high hopes for Keymed due to Chen Bo and his...
Xinyao (Criss) Wang
Follow
368 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x